Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC)
PHILADELPHIA, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is ...
Six early warning signs of skin cancer you should never ignore as Danielle Lloyd announces shock diagnosis
BRITS have been urged to look out for SIX early warning signs of skin cancer you should never ignore as Danielle Lloyd ...
Medicus Pharma Ltd: Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC)
Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is currently ...
The EMBO Journal23h
LATS1/2 inactivation in the mammary epithelium drives the evolution of a tumor-associated niche
LATS1/2-inactivation and consequent nuclear YAP/TAZ hyperactivation in the mammary epithelium drives the development of a pro ...
Scientific American18h
Tumors Hijack the Nervous System to Fuel Their Own Growth
Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...
Study sets benchmark for treatment of advanced cervical cancer
A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...
Science Daily13h
When blood cancer starts to spread
When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers report. The detailed insights into cancer ...
rsvplive13h
How Ireland's most-loved couples met, from Kian Egan to Brendan Gleeson
Today is Valentine's Day and we have the inside scoop on some of Ireland's best-known celebrity couples - scroll through the ...